TABLE OF CONTENTS
Volume 28, Issue 2 (February 2003)
Perspective
Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Affective Disorders FREE
Thomas E Schlaepfer, Markus Kosel and Charles B Nemeroff
Neuropsychopharmacology 28: 201-205; advance online publication, August 1, 2002; doi:10.1038/sj.npp.1300038
Preclinical Research
A Neurochemically Distinct Dorsal Raphe-Limbic Circuit with a Potential Role in Affective Disorders FREE
Kathryn G Commons, K Ryan Connolley and Rita J Valentino
Neuropsychopharmacology 28: 206-215; advance online publication, August 9, 2002; doi:10.1038/sj.npp.1300045
Nicotine Induces Glutamate Release from Thalamocortical Terminals in Prefrontal Cortex FREE
Evelyn K Lambe, Marina R Picciotto and George K Aghajanian
Neuropsychopharmacology 28: 216-225; doi:10.1038/sj.npp.1300032
Sensitivity to Sensorimotor Gating-Disruptive Effects of Apomorphine in two Outbred Parental Rat Strains and their F1 and N2 Progeny FREE
Neal R Swerdlow, Amanda Platten, Faith M Hanlon, Zoe A Martinez, Morton P Printz and Pamela Auerbach
Neuropsychopharmacology 28: 226-234; doi:10.1038/sj.npp.1300035
Clinical Research
Reduction of Hypothalamic Vasopressinergic Hyperdrive Contributes to Clinically Relevant Behavioral and Neuroendocrine Effects of Chronic Paroxetine Treatment in a Psychopathological Rat Model FREE
Martin E Keck, Tobias Welt, Marianne B Müller, Manfred Uhr, Frauke Ohl, Alexandra Wigger, Nicola Toschi, Florian Holsboer and Rainer Landgraf
Neuropsychopharmacology 28: 235-243; advance online publication, July 25, 2002; doi:10.1038/sj.npp.1300040
Preclinical Research
Imaging Brain Phospholipase A2 Activation in Awake Rats in Response to the 5-HT2A/2C Agonist (
)2,5-Dimethoxy-4-Iodophenyl-2-Aminopropane (DOI) FREE
Ying Qu, Lisa Chang, Justin Klaff, Andrea Balbo and Stanley I Rapoport
Neuropsychopharmacology 28: 244-252; advance online publication, June 5, 2002; doi:10.1038/sj.npp.1300022
Selective 5-HT1A Antagonists WAY 100635 and NAD-299 Attenuate the Impairment of Passive Avoidance Caused by Scopolamine in the Rat FREE
Ilga Misane and Sven Ove Ögren
Neuropsychopharmacology 28: 253-264; doi:10.1038/sj.npp.1300024
Induction of Metabolic Hypofunction and Neurochemical Deficits after Chronic Intermittent Exposure to Phencyclidine: Differential Modulation by Antipsychotic Drugs FREE
Susan M Cochran, Matthew Kennedy, Clare E McKerchar, Lucinda J Steward, Judith A Pratt and Brian J Morris
Neuropsychopharmacology 28: 265-275; doi:10.1038/sj.npp.1300031
Inhibition of 5-HT Neurotransmission Increases Clonidine Protective Effects on Naloxone-induced Conditioned Place Aversion in Morphine-dependent Rats FREE
Stéphanie Caillé, Luis Stinus, Emilio F Espejo, Philippe De Deurwaerdère, Umberto Spampinato and George F Koob
Neuropsychopharmacology 28: 276-283; advance online publication, July 15, 2002; doi:10.1038/sj.npp.1300033
Apomorphine Enhances Conditioned Responses Induced by Aversive Stimulation of the Inferior Colliculus FREE
Ana Cristina Troncoso, Mario Yukio Osaki, Suely Mason, Karina G Borelli and Marcus Lira Brandão
Neuropsychopharmacology 28: 284-291; doi:10.1038/sj.npp.1300034
Enhanced Morphine Preference Following Prolonged Abstinence: Association with Increased Fos Expression in the Extended Amygdala FREE
Glenda C Harris and Gary Aston-Jones
Neuropsychopharmacology 28: 292-299; doi:10.1038/sj.npp.1300037
Differential Effects of Haloperidol, Risperidone, and Clozapine Exposure on Cholinergic Markers and Spatial Learning Performance in Rats FREE
Alvin V Terry Jr, William D Hill, Vinay Parikh, Jennifer L Waller, Denise R Evans and Sahebarao P Mahadik
Neuropsychopharmacology 28: 300-309; advance online publication, July 25, 2002; doi:10.1038/sj.npp.1300039
Zaprinast, a Phosphodiesterase 5 Inhibitor, Overcomes Sexual Dysfunction Produced by Fluoxetine, a Selective Serotonin Reuptake Inhibitor in Hamsters FREE
Cheryl A Frye and Madeline E Rhodes
Neuropsychopharmacology 28: 310-316; doi:10.1038/sj.npp.1300051
Long-Lasting Changes in Morphine-Induced Locomotor Sensitization and Tolerance in Long-Evans Mother Rats as a Result of Periodic Postpartum Separation from the Litter: A Novel Model of Increased Vulnerability to Drug Abuse? FREE
Mikhail Kalinichev, Keith W Easterling and Stephen G Holtzman
Neuropsychopharmacology 28: 317-328; advance online publication, September 20, 2002; doi:10.1038/sj.npp.1300068
Attenuation of Cue-Controlled Cocaine-Seeking by a Selective D3 Dopamine Receptor Antagonist SB-277011-A FREE
Patricia Di Ciano, Rachel J Underwood, Jim J Hagan and Barry J Everitt
Neuropsychopharmacology 28: 329-338; advance online publication, June 18, 2002; doi:10.1038/sj.npp.1300148
Clinical Research
Acute changes in Cerebrospinal Fluid 5-HIAA following Oral Paroxetine Challenge in Healthy Humans FREE
Linda L Carpenter, George M Anderson, Jason M Siniscalchi, Phillip B Chappell and Lawrence H Price
Neuropsychopharmacology 28: 339-347; doi:10.1038/sj.npp.1300025
State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine FREE
H Murck, T Nickel, H Künzel, I A Antonijevic, J Schill, A Zobel, A Steiger, A Sonntag and F Holsboer
Neuropsychopharmacology 28: 348-358; doi:10.1038/sj.npp.1300029
A Self-Administered Questionnaire to Measure Dependence on Cigarettes: The Cigarette Dependence Scale FREE
Jean-François Etter, Jacques Le Houezec and Thomas V Perneger
Neuropsychopharmacology 28: 359-370; doi:10.1038/sj.npp.1300030
Caffeine Reversal of Ethanol Effects on the Multiple Sleep Latency Test, Memory, and Psychomotor Performance FREE
Christopher L Drake, Timothy Roehrs, Lauren Turner, Holly M Scofield and Thomas Roth
Neuropsychopharmacology 28: 371-378; advance online publication, July 15, 2002; doi:10.1038/sj.npp.1300026
Steroid Synthesis Inhibition with Ketoconazole and its Effect upon the Regulation of the Hypothalamus–Pituitary–Adrenal System in Healthy Humans FREE
Michael Deuschle, Olivera Lecei, Günther K Stalla, Rainer Landgraf, Bettina Hamann, Florian Lederbogen, Manfred Uhr, Peter Luppa, Athanasios Maras, Michael Colla and Isabella Heuser
Neuropsychopharmacology 28: 379-383; advance online publication, August 12, 2002; doi:10.1038/sj.npp.1300044
Treatment of Tourette Syndrome with Delta-9-Tetrahydrocannabinol (
9-THC): No Influence on Neuropsychological Performance FREE
Kirsten R Müller-Vahl, Heidrun Prevedel, Karen Theloe, Hans Kolbe, Hinderk M Emrich and Udo Schneider
Neuropsychopharmacology 28: 384-388; doi:10.1038/sj.npp.1300047
Saccade and Cognitive Function in Chronic Kava Users FREE
Sheree Cairney, Alan R Clough, Paul Maruff, Alex Collie, Bart J Currie and Jon Currie
Neuropsychopharmacology 28: 389-396; doi:10.1038/sj.npp.1300052
A BDNF Coding Variant is Associated with the NEO Personality Inventory Domain Neuroticism, a Risk Factor for Depression FREE
Srijan Sen, Randolph M Nesse, Scott F Stoltenberg, Sheng Li, Lillian Gleiberman, Aravinda Chakravarti, Alan B Weder and Margit Burmeister
Neuropsychopharmacology 28: 397-401; advance online publication, August 29, 2002; doi:10.1038/sj.npp.1300053
Synergistic Action of 5-HT2A Antagonists and Selective Serotonin Reuptake Inhibitors in Neuropsychiatric Disorders FREE
Gerard J Marek, Linda L Carpenter, Christopher J McDougle and Lawrence H Price
Neuropsychopharmacology 28: 402-412; advance online publication, September 13, 2002; doi:10.1038/sj.npp.1300057
Changes in Human In vivo Serotonin and Dopamine Transporter Availabilities during Chronic Antidepressant Administration FREE
Akira Kugaya, Nicholas M Seneca, Peter J Snyder, Stephen A Williams, Robert T Malison, Ronald M Baldwin, John P Seibyl and Robert B Innis
Neuropsychopharmacology 28: 413-420; advance online publication, July 19, 2002; doi:10.1038/sj.npp.1300036
